tbuckley/cabot-search huggingface dataset:
A Prospective Geriatric Assessment (GA) Study Predicting Toxicities in Older Adults (OA) with Non-Hodgkin Lymphoma (NHL): Timed up and Go Test (TUG) Time Emerges As a Functional Vital Sign
Authors: Pallawi Torka, Esther Drill, Nivetha Ganesan, Regina Truong, Annie Qiu, Walter Ramos Amador, Mayan Oliveros, Alexander P. Boardman, Philip Caron, Kevin A. David, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Steven Horwitz, Andrew M. Intlekofer, William T. Johnson, Anita Kumar, Jennifer Kimberly Lue, Efrat Luttwak, Alison Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, Raphael E. Steiner, Robert Stuver, Santosha A. Vardhana, Andrew D. Zelenetz, Gilles Salles, Paul A. Hamlin
Journal: Blood (2024)
Comparative Analysis of T Cell Profiles in Splenic Small B-Cell Malignancies
Authors: Elisavet Vlachonikola, Antonios Mingos, Philip Rock, Glykeria Gkoliou, Marina Gerousi, Maria Fitopoulou, Nikolaos Pechlivanis, Maria Karipidou, Anastasia Iatrou, Malama Galanou, Efthalia Karamanli, Nikolaos Vastarouchas, Charles C Chu, Clive S Zent, Richard Burack, Anastasia Chatzidimitriou, Kostas Stamatopoulos
Journal: Blood (2024)
Efficacy and Safety of Reduced-Doses of Post-Transplant Cyclophosphamide in Matched Peripheral Blood Stem Cell Transplantation, a Multicenter Study
Authors: Yadith Karina Lopez-Garcia, Sara Redondo Velao, Andres Gomez-De Leon, Irene García-Cadenas, Héctor Alejandro Vaquera Alfaro, Perla R. Colunga-Pedraza, Albert Esquirol, César Homero Gutierrez-Aguirre, José Carlos Jaime-Pérez, Jorge Sierra, Olga Cantu, Javier Briones, David Gomez-Almaguer, Rodrigo Martino
Journal: Blood (2024)
Structurally Optimized, IL-2-Armored CLL1 CAR-NK Cells Are Highly Potent Effectors Against AML without Hpsc Toxicity
Authors: David N. Sedloev, Qian Chen, Julia M. Unglaub, Anita Schmitt, Carsten Müller-Tidow, Michael Schmitt, Tim Sauer
Journal: Blood (2024)
Impact of Obesity on Anticoagulation Dosing and Clinical Outcomes in Pediatric Patients with Venous Thrombo-Embolism
Authors: Marie-Claude Pelland-Marcotte, Alexandra Larouche, Valerie Dollo, Gabriel Mercier, Mahukpe Narcisse U. Singbo, Chantal Ethier, Marie-Christine Boulanger
Journal: Blood (2024)
Therapeutic Targeting of the Inflammasome to Mitigate Murine Sclerodermatous Chronic Graft Versus Host Disease
Authors: Shanid Mohiyuddin, Vasantharaja Raguraman, Nashwan Jabbour, Melissa Kesler, Jayakrishna Ambati, Senthilnathan Palaniyandi, Gerhard C Hildebrandt
Journal: Blood (2024)
WUN101-01: First in Human Human (FIH) Phase 1 Study of WU-NK-101 (W-NK1) in Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)
Authors: Amanda F. Cashen, MHD Monzr M. Al Malki, Don A. Stevens, Lori Muffly, Natasha Edwin, Edward Abadir, Peter Tan, Sandrine Niyongere, Ashish Bajel, Laura Arthur, Nitin Mahajan, Ben Capoccia, Tom Leedom, Basia Muz, Kristann Magee, Ouiam Bakkacha, Justo L. Gonzalez, Deborah Masters, Stephen Moran, Eileen McNulty, Angela Pannunzio, Jayakumar Vadakekolathu, Tony Wu, Maria del Rosario, Preeta Dasgupta, Michael Munroe, Laura Simpson, Melissa M Berrien-Elliott, John Muth, Sergio Rutella, Jan K Davidson-Moncada, Todd A Fehniger
Journal: Blood (2024)
Favorable Outcomes in Pediatric R/R-ALL Following Immunotherapy with CAR-T and UCB Combined to TCR<i> <i>αβ</i> </i>-Depleted Haplo-HSCT
Authors: Huaying Liu, Dejun Chen, Jing Wang, Simeng Lv, Yuelin He, Wing Leung, Chunfu Li
Journal: Blood (2024)
<i>CblQ367P</i> Cooperates with Loss of <i>Tet2</i> to Drive a Cnl-like Disease Via the NF-Kb Pathway
Authors: Takuma Ohashi, Hiroyoshi Kunimoto, Akiko Adachi, Ayaka Miura, Takayuki Sakuma, Junji Ikeda, Yoko Ino, Jotaro Harada, Yuko Shimosato, Keita Yamamoto, Yayoi Kimura, Susumu Goyama, Satoshi Fujii, Tomohiko Tamura, Hiroaki Honda, Sheng F. Cai, Hideaki Nakajima
Journal: Blood (2024)
Inequalities in Treatment Utilization Among Older Medicare Beneficiaries with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Induction Therapy
Authors: Amer M. Zeidan, Yanqing Xu, Tatyana A. Kapustyan, Kaylee Miu, Cheng Chen, Rajesh Kamalakar, Chia-Wei Lin, Esprit Ma, Melissa Montez, Zheng Wu, Tracy Yee, Haiyan Sun, Andrew Rava, Sonia Kim, Scott F Huntington
Journal: Blood (2024)
Translational Disruption of NRF2 By Zotatifin Enhances Sensitivity to Ferroptosis and CAR-T Cells in Diffuse Large B-Cell Lymphoma
Authors: Paola Manara, Venu Venkatarame Gowda Saralamma, Austin Daniel Newsam, Marco Vincenzo Russo, Tyler Andrew Cunningham, Alicia Bilbao Martinez, Nikolai Fattakhov, Kyle Hoffman, Alexandra Marie Carbone, Abdessamad Youssfi Alaoui, Dhanvantri Chahar, Olivia Barbara Lightfuss, Francesco Maura, Daniel Bilbao, Jonathan H. Schatz
Journal: Blood (2024)
Strategy to Improve Functional T-Cell Yield in Peripheral Blood By Co-Inhibition of Beta-2 Adrenergic and CXCR4 Signaling Pathways
Authors: Devki D. Sukhtankar, Thomas Cayton, Ashley Chin, Christian Ramos, Kanchan G Jhaver, Nina Caculitan, Pina M. Cardarelli
Journal: Blood (2024)
Real-World Characteristics, Step-up Dosing Patterns, and Early Safety Outcomes of Patients with Multiple Myeloma Treated with Teclistamab within Vs. after the First Year of FDA Approval
Authors: Rahul Banerjee, Nina Kim, Monal Kohli, Emeka Umeh, Dee Lin, Gideon Aweh, Jessica Fowler, Emily Achter, Laura Hester, Sian Walker, Christina Hearty, Bingcao Wu
Journal: Blood (2024)
Infiltration of Innate Immune Cells into Tumors By Polatuzumab Vedotin Treatment Contributes to Its Antitumor Effect in Xenograft and Syngeneic Mouse Models
Authors: Mayu Tomita, Natsumi Kawasaki, Keigo Yorozu, Mitsue Kurasawa, Bansho Masutani, Nicolas Sax, Sei Shu, Yoriko Yamashita-Kashima, Shigeki Yoshiura
Journal: Blood (2024)
Prospective Evaluation of the Impact of Measurable Residual Disease (MRD) By Error Corrected Next-Generation Sequencing (NGS) with CPX-351 in Acute Myeloid Leukemia (AML)
Authors: David Sallman, Amy F McLemore, Onyee Chan, Andrew T. Kuykendall, Eric Padron, Zhuoer Xie, Alison R. Walker, David H Spencer, Rami S. Komrokji, Jeffrey E Lancet, Meagan Jacoby
Journal: Blood (2024)
Anti-Leukemia Combinatorial Efficacy of ABBV155, a B7H3-BCL-XL Inhibitor Antibody-Drug Conjugate, in Combination with Venetoclax through BCL-XL/BIM and BCL-2/BIM Complex Dissociations
Authors: Zhe Wang, Cassandra L. Ramage, Helen Ma, Haichao Zhang, Andrew Souers, Darren C Phillips, Marina Konopleva, Qi Zhang Tatarata
Journal: Blood (2024)
Superior Survival with Intensive Chemotherapy, Compared to Hypomethylating Agent + Venetoclax, in Patients with Intermediate/Adverse Risk Acute Myeloid Leukemia Unable to Proceed to Transplant
Authors: Kendall Diebold, Todd Mudd, Jay Jarodiya, Katherine Parks, Maris Hardee, Kimo Bachiashvili, Sravanti Rangaraju, Pankit Vachhani, Manuel Espinoza-Gutarra, Razan Mohty, Ravi Bhatia, Omer Jamy
Journal: Blood (2024)
The Impact of Physiotherapy Prehabilitation on Physical Fitness, Length of Stay (LoS), Readmission Rates, Quality of Life (QoL) and Patient Level Costing (PLICS) for Haematopoietic Stem Cell Transplant (HSCT) and Chimeric Antigen Receptor T- Cell (CAR-T) Recipients
Authors: Bronagh McGoldrick, Evelyn Evans, James Williams, Gemma Martin, Bronagh McGoldrick, Mary Warren, David Davies, Charis Hillberg, Kelly Fletcher, Joely Ford, Abigail Downing, James Murray, Ceri Jones, Emma Kempshall, Wendy A Ingram, Laura Ricketts, Keith Wilson
Journal: Blood (2024)
Preclinical Development of a Novel Humanized and Fc-Engineered Antibody-Drug Conjugate for the Therapy of T-Cell Acute Lymphoblastic Leukemia
Authors: Steffen Krohn, Carina Lynn Gehlert, Dorothee Winterberg, Alexander Jochimsen, Ammelie Svea Boje, Natalie Baum, Claudia D Baldus, Monika Brüggemann, Gunnar Cario, Martin Schrappe, Lennart Lenk, Martin Gramatzki, Katja Klausz, Christian Kellner, Matthias Peipp
Journal: Blood (2024)
Tandem CD19/20 CAR-T Showed Durable Efficacy in Patients with Relapsed/Refractory B-Cell Lymphoma: Interim Results from a Multicenter Phase I/II Trial
Authors: Jia Wei, Xiaoxi Zhou, Hui Luo, Yang Cao, Jiaqi Guo, Jie Zhao, Lifang Huang, Ang Zhang, Lihong Liu, Weiwei Tian, Yicheng Zhang
Journal: Blood (2024)
Overcoming NK Cell-Mediated Allograft Rejection By Anti-3rd Party Central Memory Veto CD8 T Cells through Down-Regulation of the Activating Receptor DNAM-1 on Alloreactive NK Cells
Authors: Wei-Hsin Liu, Aloukick Singh, Sandeep Yadav, Esther Bachar Lustig, Yair Reisner
Journal: Blood (2024)
Combined Single-Cell and Spatial Transcriptomics Reveals the Cellular Landscape of Bronchiolitis Obliterans Syndrome in Chronic Graft-Versus-Host Disease Mouse Model
Authors: Xiaolin Yuan, Lingbo Yi, Yibo Wu, Yishan Ye, Luxin Yang, Panpan Zhu, Zhiyang Yuan, He Huang, Shanshan Pei, Yi Luo
Journal: Blood (2024)
Myeloid Progenitor Cells with Preleukemic Immunophenotypes Are Common in Myelodysplasia-Related and <i>NPM1-</i>mutated Acute Myeloid Leukemia and Should Not be Interpreted As Measurable Residual Disease
Authors: Sanam Loghavi, Sa A. Wang, Wei-Ying Jen, Wei Wang, Hong Fang, Shaoying Li, Sofia A. Garces, Andres E Quesada, Jie Xu, Chi Young Ok, Shimin Hu, Jeffrey L. Jorgensen, Guilin Tang, Cedric Nasnas, Omer Karrar, Ghayas C. Issa, Naval Daver, Courtney D. DiNardo, Tapan M. Kadia, Hagop M. Kantarjian, L. Jeffrey Medeiros, Farhad Ravandi, Nicholas J. Short
Journal: Blood (2024)
Treatment with Asciminib As a Second Line after One Prior Tyrosine Kinase Inhibitor (TKI) in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) - a Chart Review Study in the United States
Authors: Ehab L. Atallah, Islam Sadek, David Wei, Dominick Latremouille-Viau, Carmine Rossi, Andrea Damon, Daisy Yang, Remi Bellefleur, Annie Guérin, Kejal Jadhav
Journal: Blood (2024)
<i>ADGRG1/GPR56</i> As a Marker of CD8+ Tumor-Reactive T Cells in Acute Myeloid Leukemia
Authors: Yihan Mei, Yu Liu, Wenbing Liu, Manling Chen, Qing Rao, Min Wang, Shaowei Qiu, Runxia Gu, Jianxiang Wang
Journal: Blood (2024)
Hypomethylating Agent and Venetoclax in Newly Diagnosed and Relapsed CBFβ::MYH11(+) Acute Myeloid Leukemia
Authors: Ziyu Feng, Xiaohui Hu, Weiyang Li, Ting Xu, Yang Xu, Shengli Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Suning Chen, Aining Sun, Depei Wu, Ying Wang
Journal: Blood (2024)
Clinical Application of Single-Cell MRD By Genotype and Phenotype in AML
Authors: Katarina Micin, Tiffany Nong, Ellen Madarang, Kiana Robles, Maurizio Affer, Brittney Otero, Azad Gucwa, Felipe Novoa, Sion Williams, Ana Ayupe, Yi Zhou, Justin M. Watts, Justin Taylor
Journal: Blood (2024)
Impact of Multiple High-Risk Cytogenetic Abnormalities on the Survival Outcomes of Patients with Primary Plasma Cell Leukemia
Authors: Adrian A Almodovar Diaz, Samhar Alouch, Angela Dispenzieri, Udit Yadav, Francis Buadi, David Dingli, Eli Muchtar, Nelson Leung, Taxiarchis Kourelis, Rahma M Warsame, Ronald S Go, Moritz Binder, Joselle Cook, Miriam Hobbs, Yi Lisa Hwa, Amie Fonder, Michelle G. Rogers, Suzanne R Hayman, Yi Lin, Mustaqeem A. Siddiqui, Robert A. Kyle, Morie A. Gertz, Vincent Rajkumar, Wilson I. Gonsalves
Journal: Blood (2024)
ERK1/2 Inhibition Mediates Bax Dependent Proteolysis of OPA1 and Induces Mitochondrial Cristae Remodeling to Overcome Resistance to Venetoclax
Authors: Priyanka Sharma, Natalia Baran, Qi Zhang, M. Anna Zal, Joanne Munck, Martin Sims, Bing Z. Carter, Michael Andreeff, Gautam Borthakur
Journal: Blood (2024)
Optec: A Phase 2 Study to Evaluate Outpatient Step-up Administration of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results
Authors: Robert Rifkin, Henning Schade, Gary Simmons, Christopher Yasenchak, Jessica Fowler, Thomas S. Lin, Lijuan Kang, Weiming Xu
Journal: Blood (2024)
Real-World Treatment Sequencing, Attrition Rates, and Survival Outcomes in Multiple Myeloma: A Retrospective Study over Four Decades
Authors: Luis Gerardo Rodríguez-Lobato, Anna De Daniel, Arturo Pereira, Carlos Fernández de Larrea, Natalia Tovar, M Teresa Cibeira López, David F. Moreno, José Miguel Mateos Pérez, Joan Bladé, Laura Rosinol Dachs
Journal: Blood (2024)
Real-World Comparison of Healthcare Costs and Resource Utilization Among Patients with Relapsed-Refractory Large B-Cell Lymphoma Treated with CAR T-Cell Therapy Versus Historical Standard-of-Care: A Cost-Consequence Analysis in Ontario, Canada
Authors: Tiana Kordbacheh, Anca Prica, Kelvin KW Chan, Mahmood Aminilari, Zharmaine Ante, Ning Liu, Inna Y Gong, Sita D. Bhella, Michael Crump, Abi Vijenthira, John Kuruvilla, Robert Kridel, Christine I Chen, Vishal Kukreti, Chloe Yang, Nauman Malik, David Hodgson, Danielle Rodin
Journal: Blood (2024)
Biomarker Analyses of the CC-92480-MM-001 Trial to Guide Combinatorial Strategies for Mezigdomide
Authors: Tracy T. Chow, Nicholas Stong, Saleh Tamim, Chad C. Bjorklund, Antonina Kurtova, Keyur Desai, Joseph T. Hadala, Cynthia Donahue, Phillip Koo, Yue Zhu, Jessica Katz, Anita K. Gandhi, Suzanne Trudel, Nizar J. Bahlis, Paul G. Richardson, Michael Amatangelo
Journal: Blood (2024)
Target Antigen-Expressing T Cells Facilitate CAR-T Cell Eradication of Residual CD19+ B Malignant Cells
Authors: Minghao Li, Wenjie Gong, JingWen Tan, Hongjia Zhu, Nan Xu, Liqing Kang, Xiaoyan Lou, Wei Wang, Jing Ye, Zhou Yu, Israth Jahan Tuhin, Liyun Chen, Chongsheng Qian, Meijing Liu, Ni Mei, Tong Shi, Guanghua Chen, Lei Yu, Shengli Xue, Depei Wu
Journal: Blood (2024)
Plasma Proteomics Differentiates between Patients with B-Cell Lymphomas
Authors: Haris Babačić, Nashif Mahruf Chowdhury, Mattias Berglund, Jamileh Hashemi, Jeremia Collin, Emma Pettersson, Ann-Marie Ly, Anna Nikkarinen, Gunilla Enblad, Daniel Molin, Ingrid Glimelius, Maria Pernemalm, Mats Hellström
Journal: Blood (2024)
Response-Driven Dose-Intensified Immunochemotherapy ± Autologous Stem Cell Transplantation in Previously Untreated Patients with High-Risk Aggressive B-Cell Lymphoma: Results of the DLCL002 Phase 2 Trial
Authors: Ting Xie, Wei Liu, Wenyang Huang, Huimin Liu, Weiwei Sui, Yi Wang, Wenjie Xiong, Yan Xu, Lugui Qiu, Dehui Zou
Journal: Blood (2024)
Improved Real-World Outcomes of Patients with Acute Promyelocytic Leukemia Treated with First-Line Arsenic Trioxide in Specialized Centers in Portugal through a 24/7 Phone-Based Referral: A Study from the Portuguese Acute Leukemia Group
Authors: Joana Brioso Infante, Eliana Aguiar, Ines Sá, Ines Marques, Miguel Neto, Catia Almeida, Telma Nascimento, Marta Isabel Pereira, Emilia Cortesao, Guilherme Mendes Sapinho, Julia Medeiros, Graca Esteves, Tiago Monteiro-Bras, Luisa Regadas, Ines Vieira, Filipa Saraiva, Georgy Alikhanov, Joana Santos, Patricia Ribeiro, Fernanda Trigo
Journal: Blood (2024)
A Novel Chemo-Based Reduced Intensity Haploidentical Two-Step Allogeneic Hematopoietic Stem Cell Transplantation, Results of a Prospective Clinical Trial
Authors: Alicia Bao, Xia Bi, Allison Gradone, Boula Gattas, Arpona Dev Nath, Brenda Grande, Gina Mateja, Joanne Filicko-O'Hara, William O'Hara, John Wagner, Dolores Grosso, Neal Flomenberg, Usama Gergis
Journal: Blood (2024)
Improved Hematologic Recovery with Ivosidenib in Patients with mIDH1 Relapsed or Refractory MDS: Results from a Phase 1 Substudy
Authors: Gabrielle T. Prince, Praneeth Baratam, Guillermo Garcia-Manero, Anne Angiolillo, Tarun Bhagnani, Assaf Vestin, Amir T. Fathi
Journal: Blood (2024)
Evaluation of ELN2022 Risk Stratification in NPM1 Mutated AML: A Study from the Fred Hutch and SWOG
Authors: Vivian M. Liu, Megan Othus, Rhonda E. Ries, Jasmine Naru, Era L. Pogosova-Agadjanyan, Frederick R. Appelbaum, Lan W. Beppu, Thomas R. Chauncey, Harry P. Erba, John E. Godwin, Matthew Fitzgibbon, Min Fang, Stanley C. Lee, Anna B. Moseley, Jerald P. Radich, Cheryl L. Willman, Feinan Wu, Soheil Meshinchi, Derek L. Stirewalt
Journal: Blood (2024)
Comprehensive Translatomic Analysis of Multiple Myeloma Unveils Novel Insights into Disease Pathogenesis
Authors: Lirong Liu, Le Wu, Xinyu Li, Xiaoyun Jin, Xiaoya Chen, Guangjue Tang, Huixing Zhou, Yuan Jian, Wenming Chen, Guangzhong Yang, Yan Huang, Fang Wang, Jia Yu, Wen Gao, Dong Wang
Journal: Blood (2024)
SG301, a Novel Anti-CD38 Monoclonal Antibody, in Patients with Relapsed/Refractory Multiple Myeloma: A First-in-Human, Multicentre, Phase 1 Trial
Authors: Ying Tian, Keshu Zhou, Quande Lin, Wenbin Qian, Wei Yang, Li Bao, Guolin Yuan, Xiaojing Yan, Liangming Ma, Xin Zhou, Lihong Liu, Fangbing Zhu, Xuelan Zuo, Xin Du, Xu Ji, Xuzhao Zhang, Jing Shen, Hai Zhou, Na Li, Wenming Chen
Journal: Blood (2024)
BEAM-201 for the Treatment of Relapsed and/or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL): Initial Data from the Phase (Ph) 1/2 Dose-Exploration, Dose-Expansion, Safety, and Efficacy Study of Multiplex Base-Edited Allogeneic Anti-CD7 CAR-T-Cells
Authors: Caroline Diorio, Paul Shaughnessy, Nosha Farhadfar, Anjali S. Advani, Wen-Kai Weng, Hagop Youssoufian, Guo Chen, Felicia Nguyen Brown, Bahru Habtermariam, Lalit Kumar, Jigar Patel, Shangbin (Gary) Liu, Sunita Goyal, Amy Simon, Alex C. Minella, David T. Teachey
Journal: Blood (2024)
Targeting Co-Regulatory Feedback Loop of MYC and GSPT1 By MYC/GSPT1 Dual Degradation Is Synthetic Lethal in Combination with Ven/Aza in TP53 Mutant Acute Myeloid Leukemia Stem and Progenitor Cells
Authors: Yuki Nishida, Hideaki Mizuno, Edward Ayoub, Eiji Sugihara, Lauren B. Ostermann, Shayaun Khazaei, Darah Scruggs, Po Yee Mak, Baozhen Ke, Bing Z. Carter, Abhishek Maiti, Liandong Ma, Michael Andreeff
Journal: Blood (2024)
Deciphering Clonal Evolution of Immunoglobulin Heavy Chain Locus Enhances Next-Generation Sequencing-Based Measurable Residual Disease Detection in Adult B-Acute Lymphoblastic Leukemia
Authors: Yang Dai, Bei Yu, Jie Zhang, Yu Wu, Zhidong Yang, Na Wang, Tong Chen, Libo Hu, Wanqiu Yang, Shiang Huang, Ting Liu, Xiaofei Ye
Journal: Blood (2024)
Sctalk: A Pilot Trial Using Implementation Science to Improve Documentation and Disclosure of Sickle Cell Trait during Infancy
Authors: Corinna L. Schultz, Kelsey Higgins, Alison Taggi Pinto, Morgan Thomas, Melanie L Pitone, Judith Feinson, Amanda M. Lewis, Jobayer Hossain, Kim Smith-Whitley, Lewis L Hsu, Melissa A. Alderfer
Journal: Blood (2024)
Trends and Disparities in Acute Lymphoblastic Leukemia-Related Mortality in the United States from 1999 to 2020: Insights from the CDC Wonder Database
Authors: Moazzam Shahzad, Eeman Ahmad, Shahzaib Ahmed, Umar Akram, Shoaib Ahmad, Muhammad Kashif Amin, Fatima Tuz Zahra, Muhammad Umair Mushtaq, Michael V. Jaglal
Journal: Blood (2024)
Clonal Hematopoiesis of Indeterminate Potential Does Not Impact Overall Survival in Multiple Myeloma
Authors: Farah Rexha, Joshua Gustine, Ryan Han, Rie Nakamoto-Matsubara, Cristina Panaroni, Rajib Shome, Valentina Nardi, Andrew R. Branagan, Diana Cirstea, Andrew J. Yee, Noopur Raje
Journal: Blood (2024)
Evaluation of Socioeconomic Barriers Impacting Patients with Newly Diagnosed Multiple Myeloma
Authors: Maya D. Srinivasan, John Culnan, Mehar Hora, Alexander Lazzaro, Britney Bell, Geethika Bodanapu, Cenk Yildirim, June Corrigan, Nhan V. Do, Mary T. Brophy, Nikhil C. Munshi, Raphael E. Szalat, Nathanael R. Fillmore, Camille V. Edwards
Journal: Blood (2024)
Pooled Fecal Allogenic Microbiotherapy for Refractory Gastrointestinal Acute Graft-<i>Versus</i>-Host Disease : Results from Early Access Program in Europe
Authors: Florent Malard, Michael Loschi, Thomas Cluzeau, Raynier Devillier, Faezeh Legrand, Amandine Charbonnier, Delphine Lebon, Anne Huynh, Cecile Borel, Jean-Baptiste Méar, Faustine Lhomme, Hélène Labussière-Wallet, Déborah Desmier, Niels Moya, Martin Carré, Jérôme Cornillon, Vincent Camus, Patrice Ceballos, Francesco Saraceni, Corentin Orvain, Sylvain Chantepie, Jakob Daniel Rudzki, Marie-Anne Couturier, Patrice Chevallier, Clemence Mediavilla, Gabrielle Roth-Guepin, David Beauvais, Etienne Daguindau, Karin Bilger, Stefan A. Klein, Pedro Chorao, Sarah Altmeyer, Francesca Patriarca, Marion Bruelle, Emilie Plantamura, Gianfranco Pittari, Mohamad Mohty
Journal: Blood (2024)
Evaluating Reasons for Differences in Real-World (RW) Clinical Outcomes Among Patients with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) on Covalent BTK Inhibitors (cBTKis)
Authors: Tycel Phillips, Mengyang Di, Taavy Miller, Jingru Wang, Amy Pierre, Gregory A. Maglinte, Erlene Kuizon Seymour, Yucai Wang
Journal: Blood (2024)
Characteristics of Myelodysplastic Syndromes with Idiopathic Pulmonary Fibrosis
Authors: Ines Zugasti, Samuel Urrutia, Eduardo Edelman Saul, Georgina Daher-Reyes, Mohammed Asim Amjad, Jia Wu, Koji Sasaki, Ajay Sheshadri, Guillermo Garcia-Manero
Journal: Blood (2024)
<i>GPRC5D</i> Status Impacts CD38 Expression in Multiple Myeloma
Authors: Umair Munawar, Julia Weingart, Patrick Eiring, Silvia Nerreter, Cornelia Vogt, Shilpa Kurian, Seungbin Han, Max J Steinhardt, Xiang Zhou, Markus Sauer, Hermann Einsele, Leo Rasche, Johannes Waldschmidt, K. Martin Kortüm
Journal: Blood (2024)
Efficacy and Safety of Odronextamab in Rare Subtypes of Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL): Data from a Dedicated Cohort of Other B-NHLs in the ELM-2 Study
Authors: Emmanuel Bachy, Tae Min Kim, Shang-Ju Wu, Jan Walewski, Jingxian Cai, Nickolas Sophos, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, H. Miles Prince
Journal: Blood (2024)
Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy in Relapsed and Refractory Multiple Myeloma - a Meta-Analysis
Authors: Ahmad Iftikhar, Hiba Arshad Shahani, Mohammad Ebad Ur Rehman, Muhammad Sheraz Hameed, Syed Ali Raza Abidi, Fathima Shehnaz Ayoobkhan, Rana Uzair Ahmad, Afreen Quadri, Muhammad Suhaib, Omar A Safdar, Faiz Anwer, Muhammad Husnain
Journal: Blood (2024)
Phase I Trial of Ex Vivo Expanded Donor Gamma Delta T Cell Immunotherapy to Prevent Acute Myeloid Leukemia Relapse after Allogeneic Transplantation
Authors: Nelli Bejanyan, Hany Elmariah, Jongphil Kim, Cheryl Cox, Melissa Lowden, Xiaofei Song, Hien Liu, Bin Yu, Kayla Reid, Sean J. Yoder, Christopher Cubitt, Rawan Faramand, Sayeef Mirza, Farhad Khimani, Lia Perez, Jose L. Ochoa-Bayona, Justin Boucher, Jose Alejandro Guevara, David Sallman, Jeffrey E Lancet, Joseph A. Pidala, Kumar Karyampudi, Frederick Locke, Claudio Anasetti, Marco Davila
Journal: Blood (2024)
First-in-Human Trial of BCMA-CD19 Compound CAR (cCAR) in Desensitization of Donor-Specific Anti-HLA Antibodies (DSAs) in Haploidentical Stem Cell Transplant Recipients
Authors: Fang Liu, Yu MA, Yecheng LI, Kevin G. Pinz, Xiao Wang, Masayuki Wada, Yupo Ma
Journal: Blood (2024)
Evaluation of Bone Marrow in Fanconi Anemia Patients Treated with Briquilimab Antibody-Based Conditioning and TCRαβ+ T-Cell/CD19+ B-Cell Depleted Haploidentical Grafts
Authors: Charmaine Fay Soco, Mark R. Krampf, Yan Yi Chan, Hana Hoang, Nivedita Kunte, Gopin Saini, Kenneth I. Weinberg, Robertson Parkman, Alice Bertaina, Rajni Agarwal, Matthew Porteus, Agnieszka D. Czechowicz
Journal: Blood (2024)
Influence of Siltuximab for CAR T-Cell Related CRS/Icans on CAR T-Cell Reconstitution, Function, and Clinical Outcomes
Authors: Antonio Di Stasi, Sean Patrick Bliven, Lauren Kelly Shea, Maureen Boms, Amber McKell, Rachael Shevin, Amitkumar N. Mehta, Mayur S. Narkhede
Journal: Blood (2024)
Immune Landscape and Outcomes of Patients with RNA Splicing Factor-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes Treated with Azacitidine +/- the Anti-PD-L1 Antibody Durvalumab
Authors: Jan Philipp Bewersdorf, Vanessa Hasle, Rory M. Shallis, Ethan G. Thompson, Daniel Lopes De Menezes, Shelonitda Rose, Isaac W. Boss, Lourdes Mendez, Nikolai A. Podoltsev, Maximilian Stahl, Tariq Kewan, Stephanie Halene, Torsten Haferlach, Brian Fox, Amer M. Zeidan
Journal: Blood (2024)
Impact of Pre-Transplant Depth of Response on Outcomes in Patients with Multiple Myeloma: A Report on Behalf of Pakistan Blood and Marrow Transplant Group
Authors: Raheel Iftikhar, Natasha Ali, Danyal Ahmad Ghani, Maryam Khan, Nida Anwar, Syed Waqas Imam Bokhari, Uzma Zaidi, Usman Ahmed, Shahzad Sarwar, Saima Humayun, Ayesha Iftikhar, Bushra Ahsan, Farrukh Ali Khan, Aisha Jamal, Fawad Qureshi, Munira Moosajee, Umar Zahur, Munira Borhany, Muhammad Ayaz Mir, Salman Naseem Adil
Journal: Blood (2024)